|
KIAA1429 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.95510307732638E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.566300002677E-09 |
| Normal-vs-Stage2 |
1.97245999999929E-05 |
| Normal-vs-Stage3 |
1.42870004715689E-09 |
| Normal-vs-Stage4 |
2.65899999796204E-08 |
| Stage1-vs-Stage2 |
9.468600E-01 |
| Stage1-vs-Stage3 |
2.254800E-01 |
| Stage1-vs-Stage4 |
1.779570E-01 |
| Stage2-vs-Stage3 |
4.313400E-01 |
| Stage2-vs-Stage4 |
2.867400E-01 |
| Stage3-vs-Stage4 |
6.735200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56289980957069E-10 |
| Normal-vs-AfricanAmerican |
1.086360E-02 |
| Normal-vs-Asian |
6.93199999957095E-07 |
| Caucasian-vs-AfricanAmerican |
1.491030E-01 |
| Caucasian-vs-Asian |
8.191800E-01 |
| AfricanAmerican-vs-Asian |
1.401170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.46919995561257E-09 |
| Normal-vs-Female |
4.83439954734877E-10 |
| Male-vs-Female |
4.950400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.06500000041088E-07 |
| Normal-vs-Age(41-60Yrs) |
2.47780018725052E-10 |
| Normal-vs-Age(61-80Yrs) |
4.2949000023107E-08 |
| Normal-vs-Age(81-100Yrs) |
1.301650E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.314800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.425400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.069000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.801200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.934600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.850800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.808200E-02 |
| Classical-VS-Follicular |
3.533600E-02 |
| Classical-VS-Other |
1.774420E-01 |
| Classical-VS-Normal |
2.36670000264283E-08 |
| Tall-VS-Follicular |
6.647000E-01 |
| Tall-VS-Other |
7.064800E-01 |
| Tall-VS-Normal |
1.09360000000169E-06 |
| Follicular-VS-Other |
5.692000E-01 |
| Follicular-VS-Normal |
2.44050000208773E-08 |
| Other-VS-Normal |
2.883400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.73080019602889E-10 |
| Normal-vs-N1 |
2.36980000067888E-08 |
| N0-vs-N1 |
2.018000E-01 |
|
|
